about
Clinical relevance of the Hevea brasiliensis lipid transfer protein Hev b 12In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and LimitationsSimultaneous oral mite anaphylaxis (pancake syndrome) in a father and daughter and a review of the literature.Hypersensitivity to racecadotril: a case report.Food allergy and food intolerance: diagnosis and treatment.The basophil activation test in the diagnosis of immediate drug hypersensitivity.Hazelnut allergy: a multi-faced condition with demographic and geographic characteristics.State of the art and perspectives in food allergy (part I): diagnosis.State of the art and perspectives in food allergy (part II): therapy.In vitro diagnosis of Hymenoptera venom allergy and further development of component resolved diagnostics.Allergy to illicit drugs and narcotics.Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need.In vitro diagnosis of immediate IgE-mediated drug hypersensitivity: warnings and (unmet) needs.Basophil activation tests: time for a reconsideration.Sensitization to the mammalian oligosaccharide galactose-alpha-1,3-galactose (alpha-gal): experience in a Flemish case series.Molecular allergy diagnosis: status anno 2015.Cannabis Allergy: What do We Know Anno 2015.The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.In vitro Diagnosis of Immediate Drug Hypersensitivity: Should We Go with the Flow.Flow-assisted basophil activation tests in immediate drug hypersensitivity: two decades of Antwerp experience.Quantification of specific IgE antibodies in immediate drug hypersensitivity: More shortcomings than potentials?Pros and Cons of Clinical Basophil Testing (BAT).Cannabis sativa allergy: looking through the fog.Flow cytometric analysis of drug-Induced basophil histamine release.Shellfish allergens: tropomyosin and beyond.Flowcytometric diagnosis of atracurium-induced anaphylaxis.Cefazolin Hypersensitivity: Toward Optimized Diagnosis.Sensitization profiles to peanut allergens in Belgium; cracking the code in infants, children and adults.Basophil activation tests: a diagnostic break-through in opiate allergy.Allergic Inflammation Is Associated With Coronary Instability and a Worse Clinical Outcome After Acute Myocardial Infarction.Challenge tests in the diagnosis of latex allergy.Delayed hypersensitivity to heparin in a patient with cancer: fondaparinux may be safe but needs to be tested.Basophil activation reveals divergent patient-specific responses to thermally processed peanuts.Basophil activation in the diagnosis of life-threatening hypersensitivity reaction to iodinated contrast media: a case report.The clinical role of positive latex IgE in patients with food/pollen adverse reactions.Role of basophil activation test for monitoring the immunological changes during desnsitization to cow’s milk: a case report.Human basophils: a unique biological instrument to detect the allergenicity of food.Where there's smoke, there's fire: cannabis allergy through passive exposure.Is the use of NMBA dissuaded in individuals who display positive sIgE to QAS?Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents.
P50
Q24169988-662CD594-3AB0-4C22-AAFC-91C6A18FD0D8Q33665147-605112D1-A297-4988-A69B-E8E868CE7B01Q34472907-4E62E8F7-E048-4D69-A8BB-E8D7822242B6Q34566913-C97C0BAF-E257-4CDC-8652-5840C0567807Q34809915-98CA4E71-A491-4D37-87E5-77B1FA2C6FFEQ37877266-08E532AD-605A-4EE7-9136-58D9AC3F6590Q38063218-C558E16F-FA70-429E-80D4-E3B47CAC5231Q38108869-E7DB05A9-2A0D-4B2F-AFB4-36DCFCD1FD5EQ38108870-AD765C88-39CC-49F3-AE02-E3A4EDBDB011Q38184613-B72C8A0C-021D-4EA3-978D-E49CFEE92AB8Q38192754-512D3C7D-841B-4E7C-9C30-718E1F17F1FEQ38213529-A6566CD0-8C9E-4FDA-AEB1-1F2EDA09B720Q38228926-107B1FAA-7F33-4382-843B-D7335C4096BDQ38250069-FBD3984B-640D-4C52-86DB-0A44A8316E73Q38311683-ACC28F61-590C-4420-BC68-BC4C77B21904Q38355443-344A649A-C6A1-40BF-8CB7-0411D2F30B46Q38547867-5355DE3F-01A5-4A49-AA7F-8A199938DABBQ38551689-50F321A1-ED6E-427D-9260-129CF9397907Q38622397-9F3113A9-8759-47A3-BCB2-B8C47C136A9CQ38807753-82C1418C-5259-44DF-B2BE-38E4480E93D1Q38885603-E19FA6AB-4CC9-4F0B-B9CA-D495C3754BC3Q38895325-8048A81F-3B65-4582-98C4-EA60AFC888BDQ38945359-BE9A8626-E6C4-4054-BAE8-9C37E088A5C8Q39043912-12D0D821-70E8-47C7-A461-D63C7E1BBA43Q39058750-E53D2778-DAF1-4356-8DC1-7E546989186EQ39170657-3B6BDAE8-5827-4703-8488-077598A17933Q39674228-500E5E40-29CE-4AC4-9C39-81CB8D6CE8FFQ39852919-3B5FA882-E003-48EA-BF3C-9B8D2F2E3240Q41203380-8600BB93-2566-4AB4-89F4-00FB5DD78428Q41513440-95372AFB-B875-4968-B316-30B4C47BABE0Q42964148-E0CFA3DD-ABB3-430F-B237-C3B40D2C10C5Q42970747-6B4900FB-1B3C-4D3D-957B-068FB62458E1Q44216942-2482370C-D4D9-4EB9-BB9B-642AB8D76446Q44682017-A8BCEE84-C169-446E-825A-A5B5FCC6B8F4Q45891790-EF518A6E-85E2-4416-8EE2-2FBF4E276576Q45891845-E5DF80C9-06C1-4AAB-977A-285F4B2A15B5Q46678897-9679EDF6-D427-4E4A-B24D-E54DD4C25878Q47693706-F17C4FB1-D667-40B0-BBD6-872157570011Q47904507-258C4946-2D96-4A6F-8BD5-EC9C9543A977Q47968126-59B0742A-0850-462E-97EC-AC109662EF00
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
V Sabato
@ast
V Sabato
@en
V Sabato
@es
V Sabato
@nl
V Sabato
@sl
type
label
V Sabato
@ast
V Sabato
@en
V Sabato
@es
V Sabato
@nl
V Sabato
@sl
prefLabel
V Sabato
@ast
V Sabato
@en
V Sabato
@es
V Sabato
@nl
V Sabato
@sl
P1053
B-6479-2017
P106
P31
P3829
P496
0000-0002-1321-314X